Biological characterization of the C-1300 murine neuroblastoma: an in vivo neural crest tumor model
Pons, G.; O'Dea, R.F.; Mirkin, B.L.
Cancer Research 42(9): 3719-3723
1982
ISSN/ISBN: 0008-5472 PMID: 7105037 Document Number: 190386
Document emailed within 1 workday
Related Documents
Combaret, V.; Coll, J.L.; Favrot, M.C. 1994: Expression of integrin and CD44 adhesion molecules on neuroblastoma: the relation to tumor aggressiveness and embryonic neural-crest differentiation Invasion and Metastasis 14(1-6): 156-163Nozue, A.T.; Ono, S. 1991: Effects of catecholamine and serotonin in central nervous system in newborn mice with special reference to neural crest cells; presumptive evidence of neural crest origin Anatomischer Anzeiger 173(3): 147-153
Liu, B.; Zhuang, H.; Servaes, S. 2013: Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 57(1): 21-28
Krejčí, E.; Grim, M. 2010: Isolation and characterization of neural crest stem cells from adult human hair follicles Folia Biologica 56(4): 149-157
Seeger, R.C.; Zeltzer, P.M.; Rayner, S.A. 1979: Onco-neural antigen: a new neural differentiation antigen expressed by neuroblastoma, oat cell carcinoma, Wilms' tumor, and sarcoma cells Journal of Immunology 122(4): 1548-1555
Akeson, R.; Seeger, R.C. 1977: Interspecies neural membrane antigens on cultured human and murine neuroblastoma cells Journal of Immunology 118(6): 1995-2003
LaBrosse, E.H.; Com-Nougué, C.; Zucker, J.M.; Comoy, E.; Bohuon, C.; Lemerle, J.; Schweisguth, O. 1980: Urinary excretion of 3-methoxy-4-hydroxymandelic acid and 3-methoxy-4-hydroxyphenylacetic acid by 288 patients with neuroblastoma and related neural crest tumors Cancer Research 40(6): 1995-2001
Woods, M.L.; Mayer, J.; Evans, T.G.; Hibbs, J.B. 1994: Antiparasitic effects of nitric oxide in an in vitro murine model of Chlamydia trachomatis infection and an in vivo murine model of Leishmania major infection Immunology Series 60: 179-195
Riopelle, R.J.; Haliotis, T.; Roder, J.C. 1983: Nerve growth factor receptors of human tumors of neural crest origin: characterization of binding site heterogeneity and alteration by theophylline Cancer Research 43(11): 5184-5189
Russegger, L.; Weiser, G.; Grunert, V. 1987: Intracranial manifestation of so-called "melanotic neuroectodermal tumor of infancy"--a choristoma with neural crest potentials Wiener Klinische Wochenschrift 99(18): 647-652
Habib, F.A.; Lobocki, C.; Ezhuthachan, R.; Chelladurai, M.; Preventza, O.; Mittal, V.K. 2001: Interferon alpha2b inhibits the murine melanoma cell line Cloudman S91 in vivo but not in vitro: a model for studying tumor cell-cytokine interactions American Surgeon 67(3): 257-260
Bemelmans, M.H.; Gouma, D.J.; Buurman, W.A. 1993: LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma Journal of Immunology 151(10): 5554-5562
Martínez-Criado, Y.; Cabello, R.; Fernández-Pineda, I.; Márquez, C.; Ramírez, G.; Rivas, E.; Robles, M.J.; Pardal, R.; Vega, F.M. 2013: Study of the expression of neural stem cell markers in neuroblastoma tumor samples and correlation with prognostic factors Cirugia Pediatrica: Organo Oficial de la Sociedad Espanola de Cirugia Pediatrica 26(3): 112-118
Vuk-Pavlović, S.; Opara, E.C.; Levanat, S.; Vrbanec, D.; Pavelić, K. 1986: Autocrine tumor growth regulation and tumor-associated hypoglycemia in murine melanoma B16 in vivo Cancer Research 46(5): 2208-2213
Riva, C.; Longuet, M.; Lucciano, M.; Magnan, J.; Lavieille, J.P. 2005: Implication of mitochondrial apoptosis in neural degeneration of cochlea in a murine model for presbycusis Revue de Laryngologie - Otologie - Rhinologie 126(2): 67-74
Marconi, P.; Cassone, A.; Baccarini, M.; Tissi, L.; Garaci, E.; Bonmassar, E.; Frati, L.; Bistoni, F. 1983: Relationships among tumor load, route of tumor inoculation, and response to immunochemotherapy in a murine lymphoma model Journal of the National Cancer Institute 71(2): 299-307
Fichtner, I.; Reipert, B.; Becker, M.; Lemm, M. 1993: In vivo characterization of immunogenicity of a mitoxantrone-resistant murine P388 leukemia In Vivo 7(1): 73-79
Lode, H.N.; Reisfeld, R.A.; Handgretinger, R.; Nicolaou, K.C.; Gaedicke, G.; Wrasidlo, W. 1998: Targeted therapy with a novel enediyene antibiotic calicheamicin theta(I)1 effectively suppresses growth and dissemination of liver metastases in a syngeneic model of murine neuroblastoma Cancer Research 58(14): 2925-2928
Castellanos, M.R.; Moya, G.; Cruz, R.; Lorigados, L.; Fernández, C.I.; Díaz, C.; de la Cuétara, K.; Bergado, J.; Francis, L.; Pavón, N.; González, E.; Ramos, R. 1998: Obtention and characterization of murine beta-NGF. Application in a model of cerebral aging Revista de Neurologia 26(153): 717-722
Iinuma, S.; Schomacker, K.T.; Wagnieres, G.; Rajadhyaksha, M.; Bamberg, M.; Momma, T.; Hasan, T. 1999: In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model Cancer Research 59(24): 6164-6170